Ameriprise
AFIB

Ameriprise’s Acutus Medical Inc AFIB Stock Holding History

Ameriprise’s Portfolio AFIB Stock Details AFIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-21,065
Closed -$72K – 4046
2021
Q4 		$72K Buy
+21,065
New +$119K ﹤0.01% 3892
2021
Q2 		– Sell
-13,733
Closed -$183K – 3983
2021
Q1 		$183K Sell
13,733
-197,160
-93% -$4.44M ﹤0.01% 3717
2020
Q4 		$6.08M Buy
210,893
+15,748
+8% +$426K ﹤0.01% 2133
2020
Q3 		$5.82M Buy
+195,145
New +$5.92M ﹤0.01% 1971

Other funds holding AFIB

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
KSCM
Kamunting Street Capital Management Miami Beach, Florida $179M AUM 5.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Ameriprise's AFIB Position: Q1 2022 in Review

Ameriprise sold out of Acutus Medical Inc (AFIB) in Q1 2022, closing a stake of 21,065 shares — an estimated $72K sold.

Ameriprise first reported a position in AFIB in Q3 2020 and held it in 4 quarters. The position peaked at $6.08M in Q4 2020. 65 funds tracked by Wall St. Rank hold AFIB as of Q1 2022.

  • Ameriprise reported no remaining Acutus Medical Inc position as of Q1 2022 after selling out during the quarter.
  • Ameriprise sold 21,065 Acutus Medical Inc shares in Q1 2022, an estimated $72K.
  • Ameriprise first reported a position in Acutus Medical Inc in Q3 2020 and held it in 4 quarters.
  • Ameriprise's Acutus Medical Inc position peaked at $6.08M in Q4 2020.
  • 65 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q1 2022.

Based on Ameriprise's 13F filing for Q1 2022, filed 16 May 2022.